Suppr超能文献

中国山西省神经科医生关于急性卒中静脉溶栓治疗知识的评估。

Assessment of neurologists' knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China.

作者信息

Ma Liansheng, Niu Xiaoyuan, Zhang Wei, Fang Yalan, Wang Jie

机构信息

Department of Neurology, First Hospital, Shanxi Medical University, Taiyuan, 030000, People's Republic of China.

出版信息

BMC Health Serv Res. 2017 May 18;17(1):358. doi: 10.1186/s12913-017-2300-6.

Abstract

BACKGROUND

Limitations in physicians' knowledge regarding fibrinolytic therapy for acute ischemic stroke may contribute to low rate of fibrinolytic therapy in China. Here physicians' knowledge was surveyed on intravenous fibrinolytic therapy for acute ischemic stroke.

METHODS

Neurologists (n = 175) from 27 major general hospitals in Shanxi province, P. R. China, were invited to complete questionnaires regarding their basic knowledge of intravenous fibrinolytic therapy for acute ischemic stroke. The questionnaire contained 12 multiple-choice questions. One point was assigned for a correct answer and zero point for a false or unanswered question.

RESULTS

One hundred and thirty-one neurologists (74.9%) responded to the questionnaires. The mean accuracy rate of 12 questions was 54.9 ± 25.01% (range 0.8-96.2%). The mean total score for respondents was 6.59 ± 2.03 (range 2-11). More years of experience and higher academic degrees were independent factors related to the total scores (P = 0.000 and P = 0.004, respectively).

CONCLUSIONS

The neurologists in this study were knowledge deficient in the area of intravenous fibrinolytic therapy for acute ischemic stroke. This partially accounts for the low rate of fibrinolytic therapy in China.

摘要

背景

医生对急性缺血性脑卒中溶栓治疗的知识局限性可能导致中国溶栓治疗率较低。在此对医生关于急性缺血性脑卒中静脉溶栓治疗的知识进行了调查。

方法

邀请来自中国山西省27家大型综合医院的175名神经科医生填写关于急性缺血性脑卒中静脉溶栓治疗基本知识的问卷。问卷包含12道多项选择题。答对一题得1分,答错或未答得0分。

结果

131名神经科医生(74.9%)回复了问卷。12道题的平均正确率为54.9±25.01%(范围0.8 - 96.2%)。受访者的平均总分是6.59±2.03(范围2 - 11)。更多的工作年限和更高的学历是与总分相关的独立因素(分别为P = 0.000和P = 0.004)。

结论

本研究中的神经科医生在急性缺血性脑卒中静脉溶栓治疗方面知识存在欠缺。这部分解释了中国溶栓治疗率较低的原因。

相似文献

3
Chinese neurologists' perspective on intravenous thrombolysis for acute ischemic stroke.
Brain Behav. 2017 Dec 7;8(1):e00882. doi: 10.1002/brb3.882. eCollection 2018 Jan.
5
Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage.
J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1520-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.022. Epub 2015 Apr 11.
7
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
8
Poor recognition of prompted treatment seeking even with good knowledge of stroke warning signs contribute to delayed arrival of acute ischemic stroke patients in Thailand.
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):948-52. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.044. Epub 2013 Oct 15.
9
Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1996-2003. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.010. Epub 2017 Jul 6.

引用本文的文献

本文引用的文献

4
Stroke and stroke care in China: huge burden, significant workload, and a national priority.
Stroke. 2011 Dec;42(12):3651-4. doi: 10.1161/STROKEAHA.111.635755. Epub 2011 Nov 3.
5
Barriers of thrombolysis therapy in developing countries.
Stroke Res Treat. 2011;2011:686797. doi: 10.4061/2011/686797. Epub 2011 Mar 17.
8
Thrombolysis for cerebral ischemia.
Front Neurol. 2010 Oct 29;1:139. doi: 10.3389/fneur.2010.00139. eCollection 2010.
9
Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
Int J Stroke. 2009 Aug;4(4):236. doi: 10.1111/j.1747-4949.2009.00273.x.
10
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验